Thursday, November 26, 2015   

GSK to sell oncology arm to Novartis
(04-22 14:22)

British pharmaceutical giant GlaxoSmithKline is to sell its oncology business to peer Novartis for US$16 billion and to buy the Swiss company's vaccines division, GSK announced on Tuesday.
Under a "major three-part transaction'' GSK and Novartis have agreed also to create a consumer healthcare business, according to a statement issued by GlaxoSmithKline. --AFP
Other Business breaking news:
CITIC Securities confirms China regulator’s investigation (19 mins ago)
Average US rate on 30-year mortgage slides to 3.95pc (1 hr 31 mins ago)
British bank Barclays fined US$108m over financial crimes risk (2 hrs 15 mins ago)
Hang Seng gives up gains at close (11-26 16:39)
Alibaba Group makes move on SCMP, insider says (11-26 14:28)
HK, China stocks rally (11-26 13:50)
Deere & Co posts profit, but sales of tractors, bulldozers drop (11-26 13:33)
US state demands fixes for 16,000 more Volkswagen, Audi, and Porsche diesels (11-26 13:11)
Volkswagen fined US$12.3 over dirty Tiguan diesels in Korea (11-26 12:39)
Osborne abandons UK tax credits (11-25 21:32)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.